Clin2
NCT05936346Possibly a fitRecruiting

Check safety of a Salvia extract dietary supplement

Aging

This trial tests whether a Salvia-based extract (taken like a dietary supplement) is safe and well-tolerated in generally healthy adults. It also checks whether people can follow the study diet and activity routines during the trial.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
55 years to 65 years
Study type
Interventional

Who can take part

  • You can sign an informed consent form to join
  • You are age 55 to 65 years
  • You are generally healthy based on your medical history and current checkup
  • You can keep your usual diet and sports/activity habits during the study
  • Your body weight falls within a normal range for the study (BMI 18.5 to under 30)
  • You can safely take the supplement and follow study instructions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07202403Enrolling by invitation
Dietary supplements and aging therapy trial

This trial tests dietary supplements and other treatments aimed at slowing the effects of aging. It is looking for generally healthy adults who are not taking immune-altering medications or other conflicting therapies.

New York, New York
NCT07719088Not yet recruiting· Phase 1
Research study on a new treatment for healthy volunteers

This study tests an investigational treatment in healthy volunteers to see how safe it is and how the body processes it. It may help in developing a new medicine.

Edwards, Colorado
NCT07757529Recruiting
Sage extract for thinking and memory in middle-aged adults

This study tests whether a daily sage extract supplement can improve thinking, focus, and memory in healthy middle-aged adults. If it works, it could offer a natural way to support brain health.

College Station, Texas
NCT07051603Recruiting· Phase 1
Safety study of SAL0140 in healthy Chinese adults

This study tests the safety and how the body handles a new medicine (SAL0140) in healthy people. It helps doctors find the right dose and check for side effects.

Guangzhou, Guangdong
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT06926218Not yet recruiting· Phase 1
Safety study of HSK47388 in healthy adults

This trial tests a new medicine called HSK47388 to see if it is safe and how the body processes it. It is an early-stage study in healthy adults aged 18 to 55.

Adelaide

Hear when a new Aging trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.